Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB

Q Zhao1, F S Lee

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Insights

New research identifies MEKK2 and MEKK3 as activators of the nuclear factor-kappaB (NF-kappaB) pathway, crucial for immune responses. This finding expands our understanding of NF-kappaB regulation by specific mitogen-activated protein kinase kinase kinases (MAP3Ks).

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Signaling

Background:

  • Nuclear factor-kappaB (NF-kappaB) is a key transcription factor regulating immune and inflammatory processes.
  • NF-kappaB activation involves a protein kinase cascade initiated by mitogen-activated protein kinase kinase kinases (MAP3Ks).
  • Previously, only NIK and MEKK1 were known to activate this pathway.

Purpose of the Study:

  • To investigate the role of MEKK2 and MEKK3 in activating the NF-kappaB signaling pathway.
  • To determine if MEKK2 and MEKK3 can induce IkappaB phosphorylation and subsequent NF-kappaB activation.

Main Methods:

  • In vivo experiments were conducted to assess the activation of IKK-alpha and IKK-beta by MEKK2 and MEKK3.
  • Site-specific phosphorylation of IkappaBalpha was analyzed.
  • NF-kappaB reporter gene activity was measured.
  • Dominant-negative constructs of IKK-alpha and IKK-beta were used to confirm the role of these kinases.

Main Results:

  • MEKK2 and MEKK3 were shown to activate IKK-alpha and IKK-beta in vivo.
  • These MAP3Ks induced site-specific IkappaBalpha phosphorylation.
  • MEKK2 and MEKK3 modestly activated an NF-kappaB reporter gene.
  • Dominant-negative IKKs blocked NF-kappaB activation mediated by MEKK2 and MEKK3.
  • Other MAP3Ks (MEKK4, ASK1, MLK3) did not activate the NF-kappaB pathway.

Conclusions:

  • MEKK2 and MEKK3 represent a distinct subset of MAP3Ks capable of activating the NF-kappaB pathway.
  • These findings elucidate a more comprehensive understanding of the upstream regulators of NF-kappaB signaling.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...